<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="case-report"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Vet Sci</journal-id><journal-id journal-id-type="iso-abbrev">Vet Sci</journal-id><journal-id journal-id-type="publisher-id">vetsci</journal-id><journal-title-group><journal-title>Veterinary Sciences</journal-title></journal-title-group><issn pub-type="epub">2306-7381</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40005863</article-id><article-id pub-id-type="pmc">PMC11861742</article-id><article-id pub-id-type="doi">10.3390/vetsci12020104</article-id><article-id pub-id-type="publisher-id">vetsci-12-00104</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>Intraoperative Frozen Section Biopsy for the Auxiliary Diagnosis of Transmural Intestinal Intermediate T-Cell Canine Lymphoma</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5078-7820</contrib-id><name><surname>Gaia de Sousa</surname><given-names>Felipe</given-names></name><xref rid="af1-vetsci-12-00104" ref-type="aff">1</xref><xref rid="c1-vetsci-12-00104" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Milioli</surname><given-names>Gabrielly</given-names></name><xref rid="af1-vetsci-12-00104" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Neto</surname><given-names>Jos&#x000e9; Ant&#x000f4;nio</given-names></name><xref rid="af2-vetsci-12-00104" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>de Felice</surname><given-names>Flavia</given-names></name><xref rid="af2-vetsci-12-00104" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Chaves</surname><given-names>Guilherme</given-names></name><xref rid="af3-vetsci-12-00104" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0003-1951-1003</contrib-id><name><surname>Pereira</surname><given-names>Mariana</given-names></name><xref rid="af2-vetsci-12-00104" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Lopes</surname><given-names>Hiasmyn</given-names></name><xref rid="af3-vetsci-12-00104" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5382-8037</contrib-id><name><surname>Wronski</surname><given-names>Julia</given-names></name><xref rid="af4-vetsci-12-00104" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Nakagaki</surname><given-names>Karen</given-names></name><xref rid="af4-vetsci-12-00104" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Beier</surname><given-names>Suzane</given-names></name><xref rid="af1-vetsci-12-00104" ref-type="aff">1</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>van der Weyden</surname><given-names>Louise</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-vetsci-12-00104"><label>1</label>Department of Veterinary Clinic and Surgery, Veterinary School, Federal University of Minas Gerais&#x02014;UFMG, Belo Horizonte 31620-295, Minas Gerais, Brazil; <email>gabriellybautz@ufmg.br</email> (G.M.); <email>suzanelb@ufmg.br</email> (S.B.)</aff><aff id="af2-vetsci-12-00104"><label>2</label>UniClinica Veterinary Clinic, Ita&#x000fa;na 35680-359, Minas Gerais, Brazil; <email>josenetocruz@hotmail.com</email> (J.A.N.); <email>flaviadefelice@hotmail.com</email> (F.d.F.); <email>tiamarivet@gmail.com</email> (M.P.)</aff><aff id="af3-vetsci-12-00104"><label>3</label>Zootec Diagnostic Center, Ita&#x000fa;na 35680-022, Minas Gerais, Brazil; <email>guilhermegchaves@yahoo.com.br</email> (G.C.); <email>mvhiasmynlopes@gmail.com</email> (H.L.)</aff><aff id="af4-vetsci-12-00104"><label>4</label>Celulavet Veterinary Diagnostic Center, Belo Horizonte 31365-000, Minas Gerais, Brazil; <email>juliawronski@gmail.com</email> (J.W.); <email>karenyumi@ymail.com</email> (K.N.)</aff><author-notes><corresp id="c1-vetsci-12-00104"><label>*</label>Correspondence: <email>fgaias@ufmg.br</email>; Tel.: +55-31-3409-2229</corresp></author-notes><pub-date pub-type="epub"><day>01</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>12</volume><issue>2</issue><elocation-id>104</elocation-id><history><date date-type="received"><day>09</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>26</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>27</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract abstract-type="plain-language-summary"><title>Simple Summary</title><p>Lymphomas are common tumors in dogs that originate from lymphoid tissue and can affect multiple organs and systems, often presenting as multicentric, particularly in solid lymphoid tissues such as the lymph nodes, spleen, and bone marrow. Diagnosing lymphoma can sometimes be challenging; however, a trans-surgical frozen section biopsy serves as an auxiliary method, especially when combined with cytology. Having a pathologist present during surgery can help identify the underlying cause of the problem, such as the presence of tumors in various organs. By performing a biopsy, initial suspicions can be confirmed, and it provides crucial information regarding tissue viability and the adequacy of surgical margins. If necessary, this allows for adjustments in surgical procedures. Overall, this method enhances safety during the diagnosis and management of clinical cases.</p></abstract><abstract><title>Abstract</title><p>Intestinal lymphoma is characterized by a malignant lymphoid neoplasm with multifactorial causes, variable clinical symptoms, and, in some cases, rapid progression. This article describes a case of intestinal lymphoma in a dog that had a history of diarrhea lasting two months, accompanied by episodes of hematochezia, which was treated using the CHOP 19 protocol. A seven-year-old male Golden Retriever presented to a veterinary clinic with clinical signs of diarrhea, prostration, and the presence of bloody feces, as reported by the owner. Initial examinations, including hematology, serum biochemistry, and imaging, revealed an abnormal structure in the intestinal region. Considering the circumstances, a surgical procedure was conducted with the aid of a trans-surgical frozen section biopsy. This biopsy aimed to verify the presence of the neoplasm, assess the suspected diagnosis, evaluate the viability of the surgical margins, and determine the possibility of expanding the surgical area. An enterectomy with enteroanastomosis and trans-surgical biopsy was performed, leading to an initial diagnosis of intestinal lymphoma. The tissue fragment was sent for immunohistochemistry, which ultimately confirmed the diagnosis of intestinal T-cell lymphoma. The patient underwent the CHOP protocol for 19 weeks, but during the maintenance phase, abdominal ultrasound examination findings indicated tumor recurrence. Despite being informed of the potential benefits of further chemotherapy, the owner opted not to continue treatment for the animal. Frozen section biopsy can help with diagnosis during surgery, avoiding more invasive procedures and the removal of lymph nodes, since in some cases, the systemic treatment of the disease is recommended.</p></abstract><kwd-group><kwd>canine neoplasia</kwd><kwd>immunohistochemistry</kwd><kwd>intestinal lymphoma</kwd><kwd>T cell</kwd></kwd-group><funding-group><funding-statement>This research received no external funding.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-vetsci-12-00104"><title>1. Introduction</title><p>Lymphoma is the most common hematopoietic neoplasm in dogs [<xref rid="B1-vetsci-12-00104" ref-type="bibr">1</xref>], with a frequency of 94.4% for all tumor types in Brazil [<xref rid="B2-vetsci-12-00104" ref-type="bibr">2</xref>]. It is a diverse group of neoplasms originating from the malignant transformation of lymphoreticular cells, exhibiting varying behaviors depending on the cell type involved. Lymphomas typically arise in solid lymphoid tissues and are most commonly seen in middle-aged to elderly dogs of medium to large breeds, such as Golden Retrievers, Labrador Retrievers, Boxers, German Shepherds, Setters, Rottweilers, Bernese Mountain Dogs, Dobermans, and Scottish Terriers [<xref rid="B3-vetsci-12-00104" ref-type="bibr">3</xref>,<xref rid="B4-vetsci-12-00104" ref-type="bibr">4</xref>,<xref rid="B5-vetsci-12-00104" ref-type="bibr">5</xref>]. There is no definitive evidence linking the incidence of lymphoma to a particular sex, although intact females may have a lower risk of developing the disease [<xref rid="B6-vetsci-12-00104" ref-type="bibr">6</xref>], though this requires further investigation [<xref rid="B7-vetsci-12-00104" ref-type="bibr">7</xref>]. The etiology of lymphoma is complex and multifactorial, with limited knowledge regarding specific risk factors [<xref rid="B5-vetsci-12-00104" ref-type="bibr">5</xref>,<xref rid="B8-vetsci-12-00104" ref-type="bibr">8</xref>].</p><p>Lymphoma can be classified into different subtypes based on anatomical, cytomorphological, immunophenotypic, genetic, molecular, and clinical factors [<xref rid="B9-vetsci-12-00104" ref-type="bibr">9</xref>]. However, in routine veterinary oncology, comprehensive classification of extranodal lymphomas is less commonly described compared to cutaneous lymphomas [<xref rid="B10-vetsci-12-00104" ref-type="bibr">10</xref>]. Anatomically, lymphoma is classified according to the tissues affected by the neoplastic process and can present in multicentric, intestinal (alimentary), mediastinal, cutaneous, and extranodal forms [<xref rid="B11-vetsci-12-00104" ref-type="bibr">11</xref>,<xref rid="B12-vetsci-12-00104" ref-type="bibr">12</xref>]. When lymphoma primarily affects the gastrointestinal tract, it typically presents with nonspecific and persistent signs, such as vomiting, diarrhea, lethargy, weight loss, and anorexia, with variable duration and progression [<xref rid="B11-vetsci-12-00104" ref-type="bibr">11</xref>,<xref rid="B13-vetsci-12-00104" ref-type="bibr">13</xref>]. Differential diagnosis for intestinal lymphoma include adenocarcinoma, leiomyosarcoma, leiomyoma, carcinomas, and mast cell tumors [<xref rid="B10-vetsci-12-00104" ref-type="bibr">10</xref>]. Histopathological diagnosis and immunophenotyping of lymphoma involve classifying the neoplasia based on the type of lymphocyte present in the infiltrate (T, B, or null), its proliferative activity, malignancy (low, intermediate, or high grade), and cell size (large or small) [<xref rid="B14-vetsci-12-00104" ref-type="bibr">14</xref>]. Lymphoma staging and classification are crucial for selecting the appropriate therapeutic regimen and determining the need for additional treatment options, such as surgical procedures, either alone or in combination with chemotherapy [<xref rid="B14-vetsci-12-00104" ref-type="bibr">14</xref>].</p><p>There remains a gap in the understanding of gastrointestinal lymphomas, and in some cases, diagnosis can be challenging [<xref rid="B15-vetsci-12-00104" ref-type="bibr">15</xref>]. Frozen section during surgery is a procedure that aims to aid in the diagnosis and analysis of the surgical margins of neoplasms and has been used in human medicine since 1905 [<xref rid="B16-vetsci-12-00104" ref-type="bibr">16</xref>]. This procedure is critical for the performance of accurate surgery: its outcome may guide the surgeon to continue or abort the surgical procedure [<xref rid="B17-vetsci-12-00104" ref-type="bibr">17</xref>]. In this approach, the pathologist enters the surgical room alongside the surgeon. During surgery, the samples are frozen, sectioned, and stained for examination. Based on the findings, the pathologist provides a possible diagnosis, enabling the surgeon to adjust the surgical approach accordingly. For instance, the surgeon may widen surgical margins if neoplastic cells are present, alter the method of surgery, or even decide to supplement the procedure with chemotherapy. The advantage of frozen section biopsy is that it allows for early diagnosis, expedited diagnostic&#x02013;therapeutic decision-making, and a tailored clinical&#x02013;surgical approach. However, confirmation through conventional histopathology remains necessary. This article aims to describe the case of intestinal lymphoma in a 7-year-old Golden Retriever with a two-month history of diarrhea and episodes of hematochezia, which was treated for 19 weeks using the CHOP protocol.</p></sec><sec id="sec2-vetsci-12-00104"><title>2. Case Presentation</title><p>An intact 7-year-old male Golden Retriever, weighing 31 kg, was referred to a veterinary clinic with a two-month history of diarrhea. For approximately two weeks prior to the veterinary evaluation, the dog had been experiencing vomiting and diarrhea, along with episodes of hematochezia. The owner had attempted treatment with ondansetron and probiotics, but the dog continued to lose weight (a 4 kg weight loss before the first evaluation) and exhibited signs of anorexia. During the clinical examination, the dog&#x02019;s heart rate was 132 bpm, respiratory rate was 44 breaths per minute, and mucous membranes were pale. The rectal temperature was 38.9 &#x000b0;C, capillary refill time was three seconds, and dehydration was estimated at 6%. The body condition score was 6 (on a 0&#x02013;9 scale), muscle condition score was 3, and there was palpable enlargement of the popliteal lymph nodes along with significant abdominal pain. Laboratory tests, including a complete blood count, serum biochemistry, and abdominal ultrasound examination, were requested. As symptomatic control, the following medications were prescribed: dipyrone (25 mg/kg, q8h, orally, for three days), omeprazole (0.7 mg/kg, q24h, orally, for three days), potemin B12 (15 mL, q12h, orally, for five days), ondansetron (0.5 mg/kg, q8h, orally, for two days), and probiotics (7.5 g, q12h, orally, for five days). The laboratory results revealed normochromic, non-regenerative microcytic anemia. Based on these findings, the initial suspicion was giardiasis. The following treatments were prescribed: Erythros (one tablet, q24h, for 45 days), Giardicid (25 mg/kg, q12h, for five days), and fenbendazole (50 mg/kg, q24h, for three days).</p><p>An abdominal ultrasound examination revealed significant thickening of the duodenal segment of the small intestine (0.94 cm), with loss of parietal stratification and moderate vascularization at this location. The abdominal ultrasound examination also showed an endoluminal large mucous content, reduced peristalsis, and possible impairment of intestinal transit. The colon had a normally thickened wall (descending colon 0.21 cm), with evident parietal stratification and consistent fecal content. There was also enlargement of abdominal lymph nodes near the affected area, but no significant changes were observed in the other evaluated segments. These abdominal ultrasound findings suggested the possibility of a neoplastic process in the intestinal wall, and exploratory laparotomy was recommended to assess whether resection of the affected intestinal segment would be feasible. Intussusception, foreign bodies, and inflammatory bowel disease were ruled out by clinical evaluation and abdominal ultrasound examination.</p><p>Given the worsening clinical signs and the findings on the abdominal ultrasound examination, a follow-up laboratory evaluation was performed, revealing a further decrease in hematocrit (5.5%) and a slight increase in segmented neutrophils, along with mild hypoalbuminemia. Prednisone (1 mg/kg, q24h, orally, for five days) and a soft diet were introduced before surgery to address the inflammatory response. As part of the staging process, chest radiographs (right/left latero-lateral and ventrodorsal views) were taken to rule out the presence of metastatic processes. No evidence of metastases was observed. The patient was referred for surgical intervention to remove the affected segment of the intestine, with the possibility of an enterectomy (<xref rid="vetsci-12-00104-f001" ref-type="fig">Figure 1</xref>). A pathologist assisted during the procedure to perform a frozen section biopsy, which was intended to help with diagnosis, evaluate the surgical margins in case of neoplasia, and determine the need for regional lymph node removal.</p><p>During the laparotomy, the altered intestinal loop was observed macroscopically, showing areas of necrosis, inflammation, and high vascularization (<xref rid="vetsci-12-00104-f001" ref-type="fig">Figure 1</xref>). An enterectomy was performed, and a nodular fragment was collected for cytology and frozen section biopsy (<xref rid="vetsci-12-00104-f002" ref-type="fig">Figure 2</xref>). Imprint cytology from the cut surface and frozen section biopsy from a 7.0 &#x000d7; 6.0 cm nodule in the intestinal tract were performed, along with fine-needle aspiration (FNA) cytology of a significantly enlarged mesenteric lymph node.</p><p>For cytology using FNA and imprint on the cut surface, rapid panoptic staining (Laborclin<sup>&#x000ae;</sup>, Pinhais, Paran&#x000e1;, Brazil), based on the Romanowsky method, was employed. In the case of frozen histopathological examination, macroscopic analysis was performed, followed by cleavage and freezing with 1,1,1,2-tetrafluoroethane (R134A), a refrigerant gas that has low flammability and low toxicity, used as a substitute for liquid nitrogen or CO<sub>2</sub>. Sections of approximately 5 &#x003bc;m were made using a portable freezing microtome, and the samples were stained with toluidine blue. These were then analyzed under a light microscope (Trinocular Biological Microscope model O500R-T, with a 5.3 MP ultrak HD OPT5 scientific capture camera from OPTICAM<sup>&#x000ae;,</sup> S&#x000e3;o Paulo, Brazil), during the surgical procedure. Additionally, samples were collected in 10% buffered formalin for subsequent conventional histopathological analysis in the laboratory. For the conventional examination, the samples were processed, embedded in paraffin, and sectioned at a thickness of 3 &#x003bc;m using a manual microtome (Lupetec<sup>&#x000ae;,</sup> S&#x000e3;o Carlos, S&#x000e3;o Paulo, Brazil), with the slides stained using hematoxylin and eosin.</p><p>The results from the cytology of the intestinal and mesenteric lymph nodes revealed a homogeneous population of intermediate lymphocytes. These lymphocytes had scarce, well-defined basophilic cytoplasm, which was sometimes vacuolated, and oval or occasionally cleaved nuclei with moderately prominent nucleoli. Moderate anisocytosis and anisokaryosis were observed, with approximately two mitoses present in five high-power fields (400&#x000d7;) (<xref rid="vetsci-12-00104-f003" ref-type="fig">Figure 3</xref>). Histopathology of the frozen section of the intestinal fragment showed transmural infiltration of the intestinal wall by intermediate lymphocytes arranged in solid sheaths. These lymphocytes expanded the lamina propria, multifocally infiltrated the villous epithelium, and expanded the submucosa. They also dissected between muscle fibers, infiltrated the muscular and serosal layers, and extended into the mesenteric adipose tissue (<xref rid="vetsci-12-00104-f003" ref-type="fig">Figure 3</xref>). This examination was important to guide the surgeon in the surgical approach to be taken at the time of surgery. Conventional histopathology performed later on the specimen fixed in 10% formalin confirmed the frozen section findings and intraoperative diagnosis of intermediate cell lymphoma. The sample showed 12 mitotic figures in 2.37 mm<sup>2</sup> and was classified as low-grade intermediate cell intestinal lymphoma [<xref rid="B18-vetsci-12-00104" ref-type="bibr">18</xref>,<xref rid="B19-vetsci-12-00104" ref-type="bibr">19</xref>]. For more accurate diagnostic determination, the paraffin block sample was sent for immunohistochemical analysis to establish the immunophenotype. Tissue sections were mounted on slides that had been previously silanized. Antigen retrieval was performed using the moist heat method in a steam cooker for 20&#x02013;30 min. Incubation with primary antibodies was carried out overnight at 4 &#x000b0;C. The Advance system was employed for development. Staining was performed with 3,3-diaminobenzidine, followed by counterstaining with hematoxylin. Both external and/or internal controls were used to validate the reaction. All antibodies used in the reactions were validated for cross-reactivity in canine tissue, with appropriate dilutions for this species. Immunohistochemical evaluation revealed intense lymphocyte infiltration in the intestinal mucosa, with more than 95% of the cells testing positive for CD3 (polyclonal antibody). These lymphocytes invaded the lamina propria and extended transmurally. Rare cells expressed Granzyme (polyclonal antibody), PAX5 (24/PAX-5 clone), MUM1 (BC5 clone), C-Kit (MIB-1 clone), and IBA1 (polyclonal antibody). The Ki67 proliferation marker was positive in approximately 30% of the neoplastic cells. The immunohistochemical and morphological profile supported the diagnosis of intermediate transmural intestinal T-cell lymphoma.</p><p>The animal was monitored through hematologic profiling to assess the resolution of anemia. Laboratory data from the initial diagnosis to surgical removal are shown in <xref rid="vetsci-12-00104-t001" ref-type="table">Table 1</xref>. The animal was under observation for two days and was prescribed meloxicam (0.1 mg/kg, q24h, orally, for three days), dipyrone (25 mg/kg, q8h, orally, for three days), and soft food. After discharge, the patient remained stable, with resolution of diarrhea and vomiting symptoms, but persistent anemia. Given this, hemoparasitosis was suspected after discussion with the owner, and an RT-PCR test was requested to rule out <italic toggle="yes">Babesia</italic> spp. and <italic toggle="yes">Ehrlichia</italic> spp. The test results were positive for both etiological agents, and treatment was initiated with doxycycline (10 mg/kg, SID, for 15 days) and imizole (5 mg/kg, with a second dose after 15 days).</p><p>Given the successful surgical excision of the tumor and the improvement in hematologic values, the patient was referred to an oncologist to begin the complementary chemotherapy protocol. One month after surgery, the patient was referred for follow-up with a veterinarian to initiate the CHOP chemotherapy protocol (vincristine, cyclophosphamide, doxorubicin, and prednisone) for 19 weeks [<xref rid="B20-vetsci-12-00104" ref-type="bibr">20</xref>,<xref rid="B21-vetsci-12-00104" ref-type="bibr">21</xref>]. Laboratory monitoring was conducted throughout the CHOP protocol. During treatment, the animal experienced anemia and episodes of neutropenia, which are expected side effects of chemotherapy. To manage these, macrogard (one tablet per 12 kg, PO) was prescribed, and filgrastim (5 &#x000b5;g/kg, IV) was administered as needed. The patient&#x02019;s weight increased to 37 kg (a 6 kg gain since the first treatment). The protocol was completed after 19 weeks.</p><p>A follow-up abdominal ultrasound examination performed six months after completing the CHOP protocol showed no significant changes. The animal then started a maintenance protocol with vincristine (0.7 mg/m<sup>2</sup> IV) every 15 days. However, two weeks after starting the maintenance protocol, an abdominal ultrasound examination revealed tumor recurrence. The owner was informed of the recurrence, along with the risks and treatment options, but chose not to authorize further treatment. The patient in this study survived for more than six months after starting the chemotherapy protocol.</p></sec><sec sec-type="discussion" id="sec3-vetsci-12-00104"><title>3. Discussion</title><p>Primary gastrointestinal lymphomas are those that primarily manifest in the abdominal region, without peripheral lymphadenopathy [<xref rid="B1-vetsci-12-00104" ref-type="bibr">1</xref>]. In this report, the animal was diagnosed with intestinal lymphoma through histopathological examination and immunophenotyping. While some evidence suggests a higher incidence in Golden Retrievers, the breed is not yet considered predisposed [<xref rid="B4-vetsci-12-00104" ref-type="bibr">4</xref>,<xref rid="B13-vetsci-12-00104" ref-type="bibr">13</xref>,<xref rid="B22-vetsci-12-00104" ref-type="bibr">22</xref>,<xref rid="B23-vetsci-12-00104" ref-type="bibr">23</xref>]. Intestinal lymphoma is most commonly observed in middle-aged to elderly dogs [<xref rid="B13-vetsci-12-00104" ref-type="bibr">13</xref>,<xref rid="B21-vetsci-12-00104" ref-type="bibr">21</xref>,<xref rid="B24-vetsci-12-00104" ref-type="bibr">24</xref>,<xref rid="B25-vetsci-12-00104" ref-type="bibr">25</xref>], with the average age of affected dogs being around nine years. Clinical signs consistent with intestinal lymphoma were present in the dogs studied [<xref rid="B13-vetsci-12-00104" ref-type="bibr">13</xref>,<xref rid="B24-vetsci-12-00104" ref-type="bibr">24</xref>]. As for sexual behavior, neutered males were more affected, followed by intact males [<xref rid="B24-vetsci-12-00104" ref-type="bibr">24</xref>]. In this case, the patient was a 7-year-old intact male, which aligns with reports from other authors [<xref rid="B24-vetsci-12-00104" ref-type="bibr">24</xref>].</p><p>Common clinical signs of intestinal lymphoma include diarrhea, weight loss, vomiting, inappetence, lethargy, and apathy, with less frequent occurrence of difficulty breathing, distended abdomen, and borborygmus [<xref rid="B13-vetsci-12-00104" ref-type="bibr">13</xref>,<xref rid="B24-vetsci-12-00104" ref-type="bibr">24</xref>,<xref rid="B26-vetsci-12-00104" ref-type="bibr">26</xref>]. In this report, the patient presented with diarrhea, vomiting, and weight loss, which are typical signs [<xref rid="B23-vetsci-12-00104" ref-type="bibr">23</xref>], along with reduced serum albumin levels. Weight loss in lymphoma patients is often due to impaired nutrient absorption, resulting from increased tumor infiltration and intestinal dysfunction [<xref rid="B24-vetsci-12-00104" ref-type="bibr">24</xref>]. This fact may explain, in part, the reason that animals with lymphoma experience weight loss, since there is impairment in the nutrient absorption processes; therefore, it is expected that there will be a compromise in body gain. Muscle cachexia, abdominal distension, and pain are common clinical findings [<xref rid="B24-vetsci-12-00104" ref-type="bibr">24</xref>], though in this case, only dehydration and abdominal pain were noted, probably due to diarrhea.</p><p>Laboratory findings in dogs with intestinal lymphoma are not always remarkable. In one study, approximately 43% of affected dogs had normal blood counts [<xref rid="B24-vetsci-12-00104" ref-type="bibr">24</xref>]. Hematocrit values (&#x0003c;40%) were reduced in five animals, and there was high number of platelets &#x0003e;400,000 cells/mL only in two dogs, as well as monocytosis and neutrophilia in approximately 14 and 29% of dogs, respectively [<xref rid="B24-vetsci-12-00104" ref-type="bibr">24</xref>]. The findings of the present report are in part consistent with those described by the other authors [<xref rid="B11-vetsci-12-00104" ref-type="bibr">11</xref>,<xref rid="B13-vetsci-12-00104" ref-type="bibr">13</xref>,<xref rid="B24-vetsci-12-00104" ref-type="bibr">24</xref>]. In our patient, mild changes were noted in liver enzymes (ALT), total proteins, and albumin levels, consistent with findings in other lymphoma cases, which often show hypoproteinemia due to reduced albumin and globulin, as well as altered serum calcium, urea, and creatinine [<xref rid="B24-vetsci-12-00104" ref-type="bibr">24</xref>]. Following chemotherapy, a decrease in lymphocyte counts is typically seen [<xref rid="B11-vetsci-12-00104" ref-type="bibr">11</xref>], but this was not observed in the present case.</p><p>Definitive diagnosis of lymphoma is made through histopathology and/or immunohistochemistry, which helps characterize the phenotype of the neoplasm. In this report, the lymphoma involved the intestines and associated mesenteric lymph nodes, which were affected in 48% of dogs in a similar study [<xref rid="B13-vetsci-12-00104" ref-type="bibr">13</xref>]. Intestinal lymphoma can be confined to the gastrointestinal tract or also affect other extranodal sites. Differential diagnoses like intussusception, foreign bodies, and inflammatory bowel disease were ruled out in this case.</p><p>Ultrasonographic evaluation of intestinal segments can reveal changes indicative of intestinal lymphoma [<xref rid="B1-vetsci-12-00104" ref-type="bibr">1</xref>]. In a study, nearly 80% (n = 65/84) of animals diagnosed with lymphoma underwent ultrasound, with the most common findings involving the intestine, followed by the lymph nodes and liver [<xref rid="B13-vetsci-12-00104" ref-type="bibr">13</xref>]. In the present case, ultrasound revealed signs of intestinal abnormalities, including segmental thickening, alterations in stratification, disrupted peristalsis, impaired transit, and moderate vascularization. These findings are consistent with those reported by other authors [<xref rid="B13-vetsci-12-00104" ref-type="bibr">13</xref>,<xref rid="B23-vetsci-12-00104" ref-type="bibr">23</xref>,<xref rid="B24-vetsci-12-00104" ref-type="bibr">24</xref>].</p><p>Cytological examination is a valuable diagnostic tool that helps characterize cell types through aspiration, aiding in early diagnosis. It can provide useful information about the condition and, in some cases, is indicative of patient survival [<xref rid="B27-vetsci-12-00104" ref-type="bibr">27</xref>]. In a study [<xref rid="B13-vetsci-12-00104" ref-type="bibr">13</xref>], lymphoma was diagnosed through cytological or histopathological evaluation of tissue samples in 33% of dogs, with a positive tumor confirmation in 31%. Diagnostic sample collection can be performed via endoscopy or exploratory laparotomy [paulin 2008], and cytology can also help predict prognosis [<xref rid="B27-vetsci-12-00104" ref-type="bibr">27</xref>]. In the present case, cytological examination revealed a monomorphic population of lymphocytes, predominantly intermediate in size, suggesting intermediate cell lymphoma. These findings are consistent with those reported in other studies [<xref rid="B15-vetsci-12-00104" ref-type="bibr">15</xref>,<xref rid="B27-vetsci-12-00104" ref-type="bibr">27</xref>].</p><p>Histopathological evaluation is a diagnostic method that allows for the observation and characterization of the cells within a tissue sample, including the assessment of malignancy, staging, and cellular invasion. In this case, intraoperative pathological consultation played a critical role in determining the diagnosis and prognosis of the lesion, enabling faster initiation of treatment while avoiding more invasive surgeries, as systemic treatment is essential for lymphoma. A frozen section biopsy is a diagnostic technique that allows for the analysis of tissue or organic fragments during the surgical procedure, providing a preliminary diagnosis [<xref rid="B28-vetsci-12-00104" ref-type="bibr">28</xref>]. In this case, the diagnosis made by the pathologist at the time of surgery avoided the unnecessary removal of lymph nodes or other affected tissues, in addition to conservative intestinal surgery, without removing a large segment of the intestine, since the treatment is considered systemic and non-surgical. The removal of a segment of the intestine was only because that region was obstructing the passage of contents. If the diagnosis at the time of surgery had been of another neoplasm such as sarcoma, the conduct would have been different, aiming at the removal of the entire neoplasm as treatment. The definitive diagnosis was confirmed by histopathological examination after the frozen section biopsy results [<xref rid="B28-vetsci-12-00104" ref-type="bibr">28</xref>]. The tissue sample exhibited characteristics consistent with intestinal lymphoma, showing transmural infiltration by neoplastic lymphocytes extending from the villi to the serosa and adipose tissue of the mesentery. These findings are in line with other reports [<xref rid="B15-vetsci-12-00104" ref-type="bibr">15</xref>,<xref rid="B23-vetsci-12-00104" ref-type="bibr">23</xref>], particularly in relation to small- and large-cell lymphomas; although the mitotic count indicates a low-grade lymphoma, the predominance of intermediate-sized lymphocytes may indicate a transition from low-grade to high-grade lymphoma.</p><p>Most animals affected by lymphoma present T-cell lymphomas, which exhibit high immunostaining for CD3 in both the cytoplasm and membrane [<xref rid="B12-vetsci-12-00104" ref-type="bibr">12</xref>,<xref rid="B13-vetsci-12-00104" ref-type="bibr">13</xref>,<xref rid="B29-vetsci-12-00104" ref-type="bibr">29</xref>]. T-cell lymphomas are associated with a more deleterious prognosis compared to B-cell lymphomas, as noted in the present report [<xref rid="B12-vetsci-12-00104" ref-type="bibr">12</xref>,<xref rid="B13-vetsci-12-00104" ref-type="bibr">13</xref>,<xref rid="B29-vetsci-12-00104" ref-type="bibr">29</xref>]. Immunophenotyping is currently considered a valuable tool for classifying lymphomas, with histopathology followed by immunohistochemistry of the biopsy samples being the gold standard method [<xref rid="B30-vetsci-12-00104" ref-type="bibr">30</xref>]. Identifying the immunophenotype enables better assessment and informed decisions regarding therapeutic options, particularly in terms of the lymphoma&#x02019;s behavior, chemotherapy response, and prognosis [<xref rid="B31-vetsci-12-00104" ref-type="bibr">31</xref>]. Approximately 10&#x02013;38% of lymphomas are classified as T-cell immunophenotype, with the remainder categorized as B-cell or null phenotypes [<xref rid="B12-vetsci-12-00104" ref-type="bibr">12</xref>]. In the present report, immunohistochemical analysis revealed that over 95% of cells were positive for CD3, with 30% of neoplastic cells staining positive for Ki67. There was also a reduction in Granzyme, PAX5, MUM1, C-Kit, and IBA1 expression. These immunohistochemical findings align with those reported by other authors [<xref rid="B23-vetsci-12-00104" ref-type="bibr">23</xref>,<xref rid="B24-vetsci-12-00104" ref-type="bibr">24</xref>,<xref rid="B30-vetsci-12-00104" ref-type="bibr">30</xref>,<xref rid="B32-vetsci-12-00104" ref-type="bibr">32</xref>]. In a previous study [<xref rid="B13-vetsci-12-00104" ref-type="bibr">13</xref>], immunophenotyping was performed in 22 dogs, of which 91% (n = 20/22) were diagnosed with T-cell lymphoma.</p><p>Several therapeutic options are available for tumor control, ranging from isolated neoplastic resections to combination approaches, such as surgical removal followed by chemotherapy. Chemotherapy, often in combination with multiple pharmacological agents, is the most widely used treatment modality. It can be administered with a single agent or as part of a combination therapy. Common chemotherapy protocols include L-asparaginase with CHOP (L-CHOP), monoclonal antibody therapy, and others such as MOPP (mechlorethamine, vincristine, procarbazine, and prednisone), LOPP (lomustine, vincristine, procarbazine, and prednisolone), CEOP (cyclophosphamide, vincristine, epirubicin, and prednisolone), LEOP (cyclophosphamide, vincristine, epirubicin, and lomustine), and VELCAP-TSC (vincristine, L-asparaginase, cyclophosphamide, lomustine, doxorubicin, prednisolone, procarbazine, and mechlorethamine) [<xref rid="B32-vetsci-12-00104" ref-type="bibr">32</xref>]. In one study [<xref rid="B13-vetsci-12-00104" ref-type="bibr">13</xref>], 58% (n = 49/84) of affected dogs received chemotherapy, 29% (n = 24/84) underwent surgery in combination with chemotherapy, and only 5% (n = 4/84) were treated solely by tumor removal. As with any surgical procedure, both trans- and post-surgical complications can arise, so it is essential to inform the owner about the potential risks. In the same study of 84 dogs with lymphoma, 31 dogs underwent enterectomy and enteroanastomosis as part of neoplastic control. Among these, 10% (n = 3/31) experienced complications, including septic peritonitis and fulminant pancreatitis. In the present report, the patient underwent enterectomy with enteroanastomosis without any intraoperative or postoperative complications. The patient recovered well and resumed eating easily and was subsequently placed on a chemotherapy protocol.</p><p>The patient was referred to the oncologist to initiate the adjuvant chemotherapy protocol, which is considered one of the most widely accepted treatments for intestinal lymphomas [<xref rid="B20-vetsci-12-00104" ref-type="bibr">20</xref>,<xref rid="B21-vetsci-12-00104" ref-type="bibr">21</xref>,<xref rid="B30-vetsci-12-00104" ref-type="bibr">30</xref>]. The CHOP protocol, which combines vincristine, cyclophosphamide, doxorubicin, and prednisone, remains one of the most commonly used chemotherapy regimens [<xref rid="B21-vetsci-12-00104" ref-type="bibr">21</xref>]. Although new therapeutic strategies are emerging, the CHOP protocol remains the first-line treatment [<xref rid="B20-vetsci-12-00104" ref-type="bibr">20</xref>]. The duration of the protocol typically ranges from 12 to 25 weeks [<xref rid="B20-vetsci-12-00104" ref-type="bibr">20</xref>]. In one study, the effectiveness of a 12-week versus a 19-week CHOP protocol was compared [<xref rid="B21-vetsci-12-00104" ref-type="bibr">21</xref>]. The 19-week protocol was shown to provide a longer period without relapse and a more extended remission compared to the 12-week version. As a result, the 19-week CHOP protocol was chosen for this case.</p><p>In the present report, during the 19-week CHOP protocol, the animal exhibited signs of anemia, leukopenia due to neutropenia, and occasional lymphopenia. Anemia and neutropenia are commonly observed during the 19-week CHOP treatment [<xref rid="B21-vetsci-12-00104" ref-type="bibr">21</xref>,<xref rid="B25-vetsci-12-00104" ref-type="bibr">25</xref>]. The severity of anemia was even lower in the 19-week CHOP protocol compared to the 12-week version [<xref rid="B21-vetsci-12-00104" ref-type="bibr">21</xref>]. Anemia is considered a prognostic indicator of survival in lymphoma cases [<xref rid="B33-vetsci-12-00104" ref-type="bibr">33</xref>]. Various chemotherapy protocols can be employed for treatment [<xref rid="B13-vetsci-12-00104" ref-type="bibr">13</xref>], and anemia may also be associated with paraneoplastic syndrome, a condition often observed in multicentric lymphomas [<xref rid="B34-vetsci-12-00104" ref-type="bibr">34</xref>]. Additionally, factors such as anemia, the T-cell immunophenotype, and elevated liver enzymes, like alanine aminotransferase, are linked to a reduction in overall survival time [<xref rid="B21-vetsci-12-00104" ref-type="bibr">21</xref>]. In cases of resistant lymphoma, protocols such as MOPP or MVPP may be considered, with the primary difference being the replacement of vincristine with vinblastine [<xref rid="B35-vetsci-12-00104" ref-type="bibr">35</xref>].</p><p>Furthermore, the survival time following diagnosis in these animals is generally limited, with death occurring within weeks to months [<xref rid="B13-vetsci-12-00104" ref-type="bibr">13</xref>]. In the present case, after undergoing surgical enterectomy to remove the neoplastic fragment, the patient began the chemotherapy protocol and survived for more than six months. However, after completing the CHOP chemotherapy protocol and entering the maintenance phase, tumor recurrence was observed. In a previous study [<xref rid="B21-vetsci-12-00104" ref-type="bibr">21</xref>], approximately 89.5% (n = 17/19) of the animals achieved complete remission. Following tumor excision and during the chemotherapy protocol, the animal remained free of tumor recurrence for approximately 240 days. The average overall survival in the study was 351 days, with a median progression-free survival of 245 days [<xref rid="B21-vetsci-12-00104" ref-type="bibr">21</xref>]. For animals with T-cell lymphoma, the median overall survival was longer with the 19-week CHOP protocol.</p></sec><sec sec-type="conclusions" id="sec4-vetsci-12-00104"><title>4. Conclusions</title><p>In conclusion, lymphomas can manifest clinically in various ways, influenced by factors such as location, cellular immunophenotyping, multicentric capabilities, and distinct progression patterns. In the present report, the patient was diagnosed with intestinal T-cell lymphoma and underwent a chemotherapy protocol, but experienced tumor progression and malignancy, leading to relapse shortly after completing chemotherapy. The use of a trans-surgical frozen section biopsy was useful in aiding the diagnostic determination of the tumor in this patient, providing valuable cellular characteristics of the affected area. Although diagnosis by frozen sections is auxiliary, it allowed diagnosis during surgery, assisting in surgical conduct and avoiding invasive procedures not indicated for this type of neoplasm that requires systemic treatment. Trans-surgical biopsy is a valuable tool and should be recommended for diagnosing organic, potentially tumoral lesions and to inform personalized therapeutic decision-making for each patient.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, F.G.d.S.; methodology, F.G.d.S., G.M., J.A.N., F.d.F., G.C., M.P., H.L., J.W., K.N. and S.B.; validation, F.G.d.S., G.M., J.A.N., F.d.F., G.C., M.P., H.L., J.W., K.N. and S.B.; formal analysis, F.G.d.S., G.M., J.A.N., J.W., K.N. and S.B.; investigation, F.G.d.S., G.M., J.A.N., F.d.F., G.C., M.P., H.L., J.W., K.N. and S.B.; data curation, F.G.d.S., G.M., J.A.N., F.d.F., G.C., M.P., H.L., J.W., K.N. and S.B.; writing&#x02014;original draft preparation, F.G.d.S.; writing&#x02014;review and editing, F.G.d.S., G.M., J.A.N., F.d.F., G.C., M.P., H.L., J.W., K.N. and S.B.; visualization, F.G.d.S., G.M., J.A.N., F.d.F., G.C., M.P., H.L., J.W., K.N. and S.B.; supervision, S.B.; project administration, F.G.d.S. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Informed consent was obtained from the dog&#x02019;s owner. Written informed consent was obtained from the owner for publication.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The raw data supporting the conclusions of this article will be made available by the authors on request.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>This research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The establishments had no role in the design, execution, interpretation, or writing of this study. The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-vetsci-12-00104"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zandvliet</surname><given-names>M.</given-names></name>
</person-group><article-title>Canine lymphoma: A review</article-title><source>Vet. Q.</source><year>2016</year><volume>36</volume><fpage>76</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1080/01652176.2016.1152633</pub-id><pub-id pub-id-type="pmid">26953614</pub-id>
</element-citation></ref><ref id="B2-vetsci-12-00104"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kimura</surname><given-names>K.C.</given-names></name>
<name><surname>G&#x000e1;rate</surname><given-names>A.P.</given-names></name>
<name><surname>Dagli</surname><given-names>M.L.Z.</given-names></name>
</person-group><article-title>Retrospective study of neoplasms in domestic animals: A survey between 1993 and 2002 of the Service of Animal Pathology, Department of Pathology, School of Veterinary Medicine and Animal Science, University of Sao Paulo, Southeast Brazil</article-title><source>Braz. J. Vet. Pathol.</source><year>2012</year><volume>5</volume><fpage>60</fpage><lpage>69</lpage></element-citation></ref><ref id="B3-vetsci-12-00104"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pastor</surname><given-names>M.</given-names></name>
<name><surname>Chalvet-Monfray</surname><given-names>K.</given-names></name>
<name><surname>Marchal</surname><given-names>T.</given-names></name>
<name><surname>Keck</surname><given-names>G.</given-names></name>
<name><surname>Magnol</surname><given-names>J.P.</given-names></name>
<name><surname>Fournel-Fleury</surname><given-names>C.</given-names></name>
<name><surname>Ponce</surname><given-names>F.</given-names></name>
</person-group><article-title>Genetic and Environmental Risk Indicators in Canine Non-Hodgkin&#x02019;s Lymphomas: Breed Associations and Geographic Distribution of 608 Cases Diagnosed throughout France over 1 Year</article-title><source>J. Vet. Intern. Med.</source><year>2009</year><volume>23</volume><fpage>301</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1111/j.1939-1676.2008.0255.x</pub-id><pub-id pub-id-type="pmid">19192140</pub-id>
</element-citation></ref><ref id="B4-vetsci-12-00104"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Villamil</surname><given-names>J.A.</given-names></name>
<name><surname>Henry</surname><given-names>C.J.</given-names></name>
<name><surname>Hahn</surname><given-names>A.W.</given-names></name>
<name><surname>Bryan</surname><given-names>J.N.</given-names></name>
<name><surname>Tyler</surname><given-names>J.W.</given-names></name>
<name><surname>Caldwell</surname><given-names>C.W.</given-names></name>
</person-group><article-title>Hormonal and Sex Impact on the Epidemiology of Canine Lymphoma</article-title><source>J. Cancer Epidemiol.</source><year>2009</year><volume>2009</volume><fpage>591753</fpage><pub-id pub-id-type="doi">10.1155/2009/591753</pub-id><pub-id pub-id-type="pmid">20445802</pub-id>
</element-citation></ref><ref id="B5-vetsci-12-00104"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Comazzi</surname><given-names>S.</given-names></name>
<name><surname>Marelli</surname><given-names>S.</given-names></name>
<name><surname>Cozzi</surname><given-names>M.</given-names></name>
<name><surname>Rizzi</surname><given-names>R.</given-names></name>
<name><surname>Finotello</surname><given-names>R.</given-names></name>
<name><surname>Henriques</surname><given-names>J.</given-names></name>
<name><surname>Pastor</surname><given-names>J.</given-names></name>
<name><surname>Ponce</surname><given-names>F.</given-names></name>
<name><surname>Rohrer-Bley</surname><given-names>C.</given-names></name>
<name><surname>R&#x000fc;tgen</surname><given-names>B.C.</given-names></name>
<etal/>
</person-group><article-title>Breed-associated risks for developing canine lymphoma differ among countries: An European canine lymphoma network study</article-title><source>BMC Vet. Res.</source><year>2018</year><volume>14</volume><elocation-id>232</elocation-id><pub-id pub-id-type="doi">10.1186/s12917-018-1557-2</pub-id><pub-id pub-id-type="pmid">30081964</pub-id>
</element-citation></ref><ref id="B6-vetsci-12-00104"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bell</surname><given-names>L.</given-names></name>
<name><surname>Hesketh</surname><given-names>S.</given-names></name>
</person-group><article-title>Mastiff breed mortality: A study of owner experience, dog age and longevity</article-title><source>Vet. Anim. Sci.</source><year>2021</year><volume>13</volume><fpage>100194</fpage><pub-id pub-id-type="doi">10.1016/j.vas.2021.100194</pub-id><pub-id pub-id-type="pmid">34458644</pub-id>
</element-citation></ref><ref id="B7-vetsci-12-00104"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gavazza</surname><given-names>A.</given-names></name>
<name><surname>Presciuttini</surname><given-names>S.</given-names></name>
<name><surname>Barale</surname><given-names>R.</given-names></name>
<name><surname>Lubas</surname><given-names>G.</given-names></name>
<name><surname>Gugliucci</surname><given-names>B.</given-names></name>
</person-group><article-title>Association between canine malignant lymphoma, living in industrial areas, and use of chemicals by dog owners</article-title><source>J. Vet. Intern. Med.</source><year>2001</year><volume>15</volume><fpage>190</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1111/j.1939-1676.2001.tb02310.x</pub-id><pub-id pub-id-type="pmid">11380026</pub-id>
</element-citation></ref><ref id="B8-vetsci-12-00104"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Seelig</surname><given-names>D.M.</given-names></name>
<name><surname>Avery</surname><given-names>A.C.</given-names></name>
<name><surname>Ehrhart</surname><given-names>E.J.</given-names></name>
<name><surname>Linden</surname><given-names>M.A.</given-names></name>
</person-group><article-title>The Comparative Diagnostic Features of Canine and Human Lymphoma</article-title><source>Vet. Sci.</source><year>2016</year><volume>3</volume><elocation-id>11</elocation-id><pub-id pub-id-type="doi">10.3390/vetsci3020011</pub-id><pub-id pub-id-type="pmid">28435836</pub-id>
</element-citation></ref><ref id="B9-vetsci-12-00104"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bennett</surname><given-names>P.</given-names></name>
<name><surname>Williamson</surname><given-names>P.</given-names></name>
<name><surname>Taylor</surname><given-names>R.</given-names></name>
</person-group><article-title>Review of Canine Lymphoma Treated with Chemotherapy: Outcomes and Prognostic Factors</article-title><source>Vet. Sci.</source><year>2023</year><volume>10</volume><elocation-id>342</elocation-id><pub-id pub-id-type="doi">10.3390/vetsci10050342</pub-id><pub-id pub-id-type="pmid">37235425</pub-id>
</element-citation></ref><ref id="B10-vetsci-12-00104"><label>10.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Vail</surname><given-names>D.M.</given-names></name>
<name><surname>Pinkerton</surname><given-names>M.E.</given-names></name>
<name><surname>Young</surname><given-names>K.M.</given-names></name>
</person-group><article-title>Canine Lymphoma and Lymphoid Leukemias</article-title><source>Withrow and MacEwen&#x02019;s Small Animal Clinical Oncology</source><edition>6th ed.</edition><publisher-name>Saunders</publisher-name><publisher-loc>Philadelphia, PA, USA</publisher-loc><year>2023</year><fpage>688</fpage><lpage>714</lpage></element-citation></ref><ref id="B11-vetsci-12-00104"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sogame</surname><given-names>N.</given-names></name>
<name><surname>Risbon</surname><given-names>R.</given-names></name>
<name><surname>Burgess</surname><given-names>K.E.</given-names></name>
</person-group><article-title>Intestinal lymphoma in dogs: 84 cases (1997&#x02013;2012)</article-title><source>JAVMA</source><year>2018</year><volume>252</volume><fpage>440</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.2460/javma.252.4.440</pub-id><pub-id pub-id-type="pmid">29393741</pub-id>
</element-citation></ref><ref id="B12-vetsci-12-00104"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hayes</surname><given-names>A.</given-names></name>
<name><surname>Hughes</surname><given-names>K.</given-names></name>
<name><surname>Hare</surname><given-names>C.</given-names></name>
<name><surname>Peschard</surname><given-names>L.</given-names></name>
<name><surname>Lara</surname><given-names>A.S.</given-names></name>
<name><surname>Schiavo</surname><given-names>L.</given-names></name>
<name><surname>Dobson</surname><given-names>J.</given-names></name>
</person-group><article-title>T-cell lymphoma involving the rectum of a dog</article-title><source>J. Comp. Pathol.</source><year>2023</year><volume>207</volume><fpage>87</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.jcpa.2023.10.009</pub-id><pub-id pub-id-type="pmid">37995445</pub-id>
</element-citation></ref><ref id="B13-vetsci-12-00104"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Paulin</surname><given-names>M.V.</given-names></name>
<name><surname>Couronn&#x000e9;</surname><given-names>L.</given-names></name>
<name><surname>Beguin</surname><given-names>J.</given-names></name>
<name><surname>Le Poder</surname><given-names>S.</given-names></name>
<name><surname>Delverdier</surname><given-names>M.</given-names></name>
<name><surname>Semin</surname><given-names>M.O.</given-names></name>
<name><surname>Bruneau</surname><given-names>J.</given-names></name>
<name><surname>Cerf-Bensussan</surname><given-names>N.</given-names></name>
<name><surname>Malamut</surname><given-names>G.</given-names></name>
<name><surname>Cellier</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>Feline low-grade alimentary lymphoma: An emerging entity and a potential animal model for human disease</article-title><source>BMC Vet. Res.</source><year>2018</year><volume>14</volume><elocation-id>306</elocation-id><pub-id pub-id-type="doi">10.1186/s12917-018-1635-5</pub-id><pub-id pub-id-type="pmid">30305106</pub-id>
</element-citation></ref><ref id="B14-vetsci-12-00104"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vos</surname><given-names>N.</given-names></name>
<name><surname>Pellin</surname><given-names>M.</given-names></name>
<name><surname>Vail</surname><given-names>D.M.</given-names></name>
</person-group><article-title>A comparison of 12- and 19-week CHOP protocols using non-randomized, contemporaneous controls</article-title><source>Vet. Comp. Oncol.</source><year>2019</year><volume>17</volume><fpage>276</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1111/vco.12465</pub-id><pub-id pub-id-type="pmid">31140707</pub-id>
</element-citation></ref><ref id="B15-vetsci-12-00104"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Matsumoto</surname><given-names>I.</given-names></name>
<name><surname>Uchida</surname><given-names>K.</given-names></name>
<name><surname>Nakashima</surname><given-names>K.</given-names></name>
<name><surname>Goto-Koshino</surname><given-names>Y.</given-names></name>
<name><surname>Chambers</surname><given-names>J.K.</given-names></name>
<name><surname>Tsujimoto</surname><given-names>H.</given-names></name>
<name><surname>Nakayama</surname><given-names>H.</given-names></name>
</person-group><article-title>Pathological features of intestinal T-cell lymphoma in Shiba dogs in Japan</article-title><source>Vet. Comp. Oncol.</source><year>2018</year><volume>16</volume><fpage>417</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1111/vco.12396</pub-id><pub-id pub-id-type="pmid">29575510</pub-id>
</element-citation></ref><ref id="B16-vetsci-12-00104"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gal</surname><given-names>A.A.</given-names></name>
<name><surname>Cagle</surname><given-names>P.T.</given-names></name>
</person-group><article-title>The 100-year anniversary of the description of the frozen section procedure</article-title><source>JAMA</source><year>2005</year><volume>294</volume><fpage>3135</fpage><lpage>3137</lpage><pub-id pub-id-type="doi">10.1001/jama.294.24.3135</pub-id><pub-id pub-id-type="pmid">16380595</pub-id>
</element-citation></ref><ref id="B17-vetsci-12-00104"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wick</surname><given-names>M.R.</given-names></name>
</person-group><article-title>Intraoperative consultations in pathology: A current perspective</article-title><source>Am. J. Clin. Pathol.</source><year>1995</year><volume>104</volume><fpage>239</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1093/ajcp/104.3.239</pub-id><pub-id pub-id-type="pmid">7677109</pub-id>
</element-citation></ref><ref id="B18-vetsci-12-00104"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Valli</surname><given-names>V.E.</given-names></name>
<name><surname>Myint</surname><given-names>M.S.</given-names></name>
<name><surname>Barthel</surname><given-names>A.</given-names></name>
<name><surname>Bienzle</surname><given-names>D.</given-names></name>
<name><surname>Caswell</surname><given-names>J.</given-names></name>
<name><surname>Colbatzky</surname><given-names>F.</given-names></name>
<name><surname>Durham</surname><given-names>A.</given-names></name>
<name><surname>Ehrhart</surname><given-names>E.</given-names></name>
<name><surname>Johnson</surname><given-names>C.</given-names></name>
<name><surname>Jones</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Classification of canine malignant lymphomas according to the World Health Organization criteria</article-title><source>Vet. Pathol.</source><year>2011</year><volume>48</volume><fpage>198</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1177/0300985810379428</pub-id><pub-id pub-id-type="pmid">20861499</pub-id>
</element-citation></ref><ref id="B19-vetsci-12-00104"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rigillo</surname><given-names>A.</given-names></name>
<name><surname>Fuchs-Baumgartinger</surname><given-names>A.</given-names></name>
<name><surname>Sabattini</surname><given-names>S.</given-names></name>
<name><surname>&#x00160;kor</surname><given-names>O.</given-names></name>
<name><surname>Agnoli</surname><given-names>C.</given-names></name>
<name><surname>Schwendenwein</surname><given-names>I.</given-names></name>
<name><surname>Bettini</surname><given-names>G.</given-names></name>
<name><surname>R&#x000fc;tgen</surname><given-names>B.C.</given-names></name>
</person-group><article-title>Ki-67 assessment&#x02014;Agreeability between immunohistochemistry and flow cytometry in canine lymphoma</article-title><source>Vet. Comp. Oncol.</source><year>2021</year><volume>19</volume><fpage>551</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1111/vco.12694</pub-id><pub-id pub-id-type="pmid">33759339</pub-id>
</element-citation></ref><ref id="B20-vetsci-12-00104"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Matsumoto</surname><given-names>I.</given-names></name>
<name><surname>Nakashima</surname><given-names>K.</given-names></name>
<name><surname>Goto-Koshino</surname><given-names>Y.</given-names></name>
<name><surname>Chambers</surname><given-names>J.K.</given-names></name>
<name><surname>Tsujimoto</surname><given-names>H.</given-names></name>
<name><surname>Nakayama</surname><given-names>H.</given-names></name>
<name><surname>Uchida</surname><given-names>K.</given-names></name>
</person-group><article-title>Immunohistochemical Profiling of Canine Intestinal T-Cell Lymphomas</article-title><source>Vet. Pathol.</source><year>2019</year><volume>56</volume><fpage>50</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1177/0300985818800015</pub-id><pub-id pub-id-type="pmid">30278836</pub-id>
</element-citation></ref><ref id="B21-vetsci-12-00104"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thamm</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Novel Treatments for Lymphoma</article-title><source>Vet. Clin. N. Am. Small Anim. Pract.</source><year>2024</year><volume>54</volume><fpage>477</fpage><lpage>490</lpage><pub-id pub-id-type="doi">10.1016/j.cvsm.2023.12.004</pub-id><pub-id pub-id-type="pmid">38199913</pub-id>
</element-citation></ref><ref id="B22-vetsci-12-00104"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Curran</surname><given-names>K.</given-names></name>
<name><surname>Thamm</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Retrospective analysis for treatment of na&#x000ef;ve canine multicentric lymphoma with a 15-week, maintenance-free CHOP protocol</article-title><source>Vet. Comp. Oncol.</source><year>2016</year><volume>14</volume><fpage>147</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1111/vco.12163</pub-id><pub-id pub-id-type="pmid">26279153</pub-id>
</element-citation></ref><ref id="B23-vetsci-12-00104"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Luethcke</surname><given-names>K.R.</given-names></name>
<name><surname>Trepanier</surname><given-names>L.A.</given-names></name>
<name><surname>Tindle</surname><given-names>A.N.</given-names></name>
<name><surname>Labadie</surname><given-names>J.D.</given-names></name>
</person-group><article-title>Environmental exposures and lymphoma risk: A nested case-control study using the Golden Retriever Lifetime Study cohort</article-title><source>Canine Med. Gen.</source><year>2022</year><volume>9</volume><fpage>10</fpage><pub-id pub-id-type="doi">10.1186/s40575-022-00122-9</pub-id></element-citation></ref><ref id="B24-vetsci-12-00104"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gieger</surname><given-names>T.</given-names></name>
</person-group><article-title>Alimentary Lymphoma in Cats and Dogs</article-title><source>Vet. Clin. N. Am. Small Anim. Pract.</source><year>2011</year><volume>41</volume><fpage>419</fpage><lpage>432</lpage><pub-id pub-id-type="doi">10.1016/j.cvsm.2011.02.001</pub-id></element-citation></ref><ref id="B25-vetsci-12-00104"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Couto</surname><given-names>K.M.</given-names></name>
<name><surname>Moore</surname><given-names>P.F.</given-names></name>
<name><surname>Zwingenberger</surname><given-names>A.L.</given-names></name>
<name><surname>Willcox</surname><given-names>J.L.</given-names></name>
<name><surname>Skorupski</surname><given-names>K.A.</given-names></name>
</person-group><article-title>Clinical characteristics and outcome in dogs with small cell T-cell intestinal lymphoma</article-title><source>Vet. Comp. Oncol.</source><year>2018</year><volume>16</volume><fpage>337</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1111/vco.12384</pub-id><pub-id pub-id-type="pmid">29322604</pub-id>
</element-citation></ref><ref id="B26-vetsci-12-00104"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maeda</surname><given-names>S.</given-names></name>
<name><surname>Tsuboi</surname><given-names>M.</given-names></name>
<name><surname>Sakai</surname><given-names>K.</given-names></name>
<name><surname>Ohno</surname><given-names>K.</given-names></name>
<name><surname>Fukushima</surname><given-names>K.</given-names></name>
<name><surname>Kanemoto</surname><given-names>H.</given-names></name>
<name><surname>Hiyoshi-Kanemoto</surname><given-names>S.</given-names></name>
<name><surname>Goto-Koshino</surname><given-names>Y.</given-names></name>
<name><surname>Chambers</surname><given-names>J.K.</given-names></name>
<name><surname>Yonezawa</surname><given-names>T.</given-names></name>
<etal/>
</person-group><article-title>Endoscopic Cytology for the Diagnosis of Chronic Enteritis and Intestinal Lymphoma in Dogs</article-title><source>Vet. Pathol.</source><year>2017</year><volume>54</volume><fpage>595</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1177/0300985817705175</pub-id><pub-id pub-id-type="pmid">28494704</pub-id>
</element-citation></ref><ref id="B27-vetsci-12-00104"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jankowska</surname><given-names>U.</given-names></name>
<name><surname>Jagielski</surname><given-names>D.</given-names></name>
<name><surname>Czopowicz</surname><given-names>M.</given-names></name>
<name><surname>Sapierzy&#x00144;ski</surname><given-names>R.</given-names></name>
</person-group><article-title>Epidemiology, clinical and cytological features of lymphoma in Boxer dogs</article-title><source>Acta Vet. Hung.</source><year>2019</year><volume>67</volume><fpage>224</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1556/004.2019.024</pub-id><pub-id pub-id-type="pmid">31238736</pub-id>
</element-citation></ref><ref id="B28-vetsci-12-00104"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Garcia</surname><given-names>M.T.</given-names></name>
<name><surname>Mota</surname><given-names>B.S.</given-names></name>
<name><surname>Cardoso</surname><given-names>N.</given-names></name>
<name><surname>Martimbianco</surname><given-names>A.L.</given-names></name>
<name><surname>Ricci</surname><given-names>M.D.</given-names></name>
<name><surname>Carvalho</surname><given-names>F.M.</given-names></name>
<name><surname>Gon&#x000e7;alves</surname><given-names>R.</given-names></name>
<name><surname>Soares Junior</surname><given-names>J.M.</given-names></name>
<name><surname>Filassi</surname><given-names>J.R.</given-names></name>
</person-group><article-title>Accuracy of frozen section in intraoperative margin assessment for breast-conserving surgery: A systematic review and meta-analysis</article-title><source>PLoS ONE</source><year>2021</year><volume>16</volume><elocation-id>e0248768</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0248768</pub-id><pub-id pub-id-type="pmid">33735315</pub-id>
</element-citation></ref><ref id="B29-vetsci-12-00104"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Einhorn</surname><given-names>A.</given-names></name>
<name><surname>Dank</surname><given-names>G.</given-names></name>
<name><surname>Hanael</surname><given-names>E.</given-names></name>
<name><surname>Kent</surname><given-names>M.S.</given-names></name>
<name><surname>Clifford</surname><given-names>C.A.</given-names></name>
<name><surname>Dunaevich</surname><given-names>A.</given-names></name>
<name><surname>Yas</surname><given-names>E.</given-names></name>
</person-group><article-title>Outcomes and prognostic factors in canine T cell lymphoma treated with lomustine, vincristine, cyclophosphamide, and prednisone chemotherapy</article-title><source>Vet. Oncol.</source><year>2024</year><volume>1</volume><fpage>6</fpage><pub-id pub-id-type="doi">10.1186/s44356-024-00007-y</pub-id></element-citation></ref><ref id="B30-vetsci-12-00104"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Valli</surname><given-names>V.E.</given-names></name>
<name><surname>Kass</surname><given-names>P.H.</given-names></name>
<name><surname>San Myint</surname><given-names>M.</given-names></name>
<name><surname>Scott</surname><given-names>F.</given-names></name>
</person-group><article-title>Canine lymphomas: Association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival</article-title><source>Vet. Pathol.</source><year>2013</year><volume>50</volume><fpage>738</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1177/0300985813478210</pub-id><pub-id pub-id-type="pmid">23444036</pub-id>
</element-citation></ref><ref id="B31-vetsci-12-00104"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sayag</surname><given-names>D.</given-names></name>
<name><surname>Fournel-Fleury</surname><given-names>C.</given-names></name>
<name><surname>Ponce</surname><given-names>F.</given-names></name>
</person-group><article-title>Prognostic significance of morphotypes in canine lymphomas: A systematic review of literature</article-title><source>Vet. Comp. Oncol.</source><year>2018</year><volume>16</volume><fpage>12</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1111/vco.12320</pub-id><pub-id pub-id-type="pmid">28524622</pub-id>
</element-citation></ref><ref id="B32-vetsci-12-00104"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Howard</surname><given-names>C.M.</given-names></name>
<name><surname>Anderson</surname><given-names>S.</given-names></name>
<name><surname>Harrington</surname><given-names>B.</given-names></name>
</person-group><article-title>Characterization of CD3+/CD20+ canine large-cell lymphoma</article-title><source>J. Vet. Diag. Investig.</source><year>2024</year><volume>36</volume><fpage>86</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1177/10406387231204873</pub-id><pub-id pub-id-type="pmid">37837199</pub-id>
</element-citation></ref><ref id="B33-vetsci-12-00104"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miller</surname><given-names>A.</given-names></name>
<name><surname>Morley</surname><given-names>P.S.</given-names></name>
<name><surname>Rao</surname><given-names>S.</given-names></name>
<name><surname>Avery</surname><given-names>A.C.</given-names></name>
<name><surname>Lana</surname><given-names>S.E.</given-names></name>
<name><surname>Olver</surname><given-names>C.S.</given-names></name>
</person-group><article-title>Anemia is associated with decreased survival time in dogs with lymphoma</article-title><source>J. Vet. Intern. Med.</source><year>2009</year><volume>23</volume><fpage>116</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1111/j.1939-1676.2008.0210.x</pub-id><pub-id pub-id-type="pmid">19138381</pub-id>
</element-citation></ref><ref id="B34-vetsci-12-00104"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>E.-H.</given-names></name>
<name><surname>Lee</surname><given-names>J.-J.</given-names></name>
<name><surname>Liao</surname><given-names>A.T.</given-names></name>
<name><surname>Wang</surname><given-names>S.-L.</given-names></name>
</person-group><article-title>Paraneoplastic Syndrome as a Prognostic Factors in Dogs with Multicentric Lymphoma</article-title><source>Int. J. Appl. Res. Vet. Med.</source><year>2020</year><volume>18</volume><fpage>131</fpage><lpage>141</lpage></element-citation></ref><ref id="B35-vetsci-12-00104"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zimmerman</surname><given-names>K.</given-names></name>
<name><surname>Walsh</surname><given-names>K.A.</given-names></name>
<name><surname>Ferrari</surname><given-names>J.T.</given-names></name>
<name><surname>Keuler</surname><given-names>N.S.</given-names></name>
<name><surname>Atherton</surname><given-names>M.J.</given-names></name>
<name><surname>Lenz</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma</article-title><source>Vet. Comp. Oncol.</source><year>2023</year><volume>21</volume><fpage>503</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1111/vco.12913</pub-id><pub-id pub-id-type="pmid">37222086</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="vetsci-12-00104-f001"><label>Figure 1</label><caption><p>(<bold>A</bold>) Location of the lymphoma in the intestinal loop of the evaluated patient. Altered anatomical segments can be seen, with foci of necrosis, inflammation, and high vascularization (arrowhead). (<bold>B</bold>) Delimitation of the intestinal neoplastic process (yellow dashed line).</p></caption><graphic xlink:href="vetsci-12-00104-g001" position="float"/></fig><fig position="float" id="vetsci-12-00104-f002"><label>Figure 2</label><caption><p>(<bold>A</bold>) Intestinal fragment removed after tumor excision for evaluation by frozen section biopsy, conventional histopathology, and immunohistochemistry; (<bold>B</bold>) Intestinal loop after enterectomy procedure associated with enteroanastomosis.</p></caption><graphic xlink:href="vetsci-12-00104-g002" position="float"/></fig><fig position="float" id="vetsci-12-00104-f003"><label>Figure 3</label><caption><p>Alimentary lymphoma. (<bold>A</bold>,<bold>B</bold>) Cytology of the intestinal nodule and mesenteric lymph node showing moderate to high cellularity, composed of a monomorphic population of intermediate-sized lymphocytes, with occasionally prominent nucleoli. Stained with rapid panoptic, 400&#x000d7; magnification. (<bold>C</bold>) Frozen section revealing lymphocytes infiltrating adipose tissue in the intestinal serosa and mesenteric region. Stained with toluidine blue, 400&#x000d7; magnification. (<bold>D</bold>,<bold>E</bold>) Conventional histological sections demonstrating the expansion and diffuse infiltration of intestinal villi and adipocytes. Stained with H&#x00026;E, 100&#x000d7; magnification. (<bold>F</bold>) Conventional histological sections showing the proliferation of a monomorphic population of intermediate lymphocytes forming a cell mantle, with occasional mitotic figures. Stained with H&#x00026;E, 400&#x000d7; magnification.</p></caption><graphic xlink:href="vetsci-12-00104-g003" position="float"/></fig><table-wrap position="float" id="vetsci-12-00104-t001"><object-id pub-id-type="pii">vetsci-12-00104-t001_Table 1</object-id><label>Table 1</label><caption><p>Results observed in the patient&#x02019;s laboratory tests throughout the clinical care until the surgical procedure and resolution.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Year 2023</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">19<break/>July</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">02<break/>August</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">07<break/>August</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">10<break/>August</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">05<break/>September</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">19<break/>September</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference for Adult Dogs</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Erythrogram</bold>
</td><td colspan="7" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hematocrit (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>35.30</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>29.80</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>26.40</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>35.40</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>34.90</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">37.0&#x02013;55.0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hemoglobin (g/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">12.30</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>9.60</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>8.60</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">12.30</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>11.40</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">12.0&#x02013;18.0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">RBC (&#x000d7;10<sup>6</sup>/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.10</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>5.00</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>4.60</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>5.40</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">5.50</td><td align="center" valign="middle" rowspan="1" colspan="1">5.5&#x02013;8.5</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MCM (fL)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>58.30</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>59.40</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>57.80</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">65.60</td><td align="center" valign="middle" rowspan="1" colspan="1">63.50</td><td align="center" valign="middle" rowspan="1" colspan="1">60.0&#x02013;77.0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MCHC (g/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">34.80</td><td align="center" valign="middle" rowspan="1" colspan="1">32.20</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">32.60</td><td align="center" valign="middle" rowspan="1" colspan="1">34.70</td><td align="center" valign="middle" rowspan="1" colspan="1">32.70</td><td align="center" valign="middle" rowspan="1" colspan="1">32.0&#x02013;36.0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MCH (pg)</td><td align="center" valign="middle" rowspan="1" colspan="1">20.30</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>19.10</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>18.80</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">22.80</td><td align="center" valign="middle" rowspan="1" colspan="1">20.70</td><td align="center" valign="middle" rowspan="1" colspan="1">19.5&#x02013;24.5</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Erythroblast (cells/100 WBC)</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Platelets (&#x000d7;10<sup>6</sup> cells/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">331</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">349</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">274</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">310</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">380</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">175&#x02013;500</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Leukogram</bold>
</td><td colspan="7" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Total WBC (cells/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">9900</td><td align="center" valign="middle" rowspan="1" colspan="1">16,100</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">14,000</td><td align="center" valign="middle" rowspan="1" colspan="1">8900</td><td align="center" valign="middle" rowspan="1" colspan="1">11,700</td><td align="center" valign="middle" rowspan="1" colspan="1">6000&#x02013;17,000</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Rods (cells/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0&#x02013;300</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Segmented (cells/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">7425</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>13,685</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">11,340</td><td align="center" valign="middle" rowspan="1" colspan="1">6319</td><td align="center" valign="middle" rowspan="1" colspan="1">8892</td><td align="center" valign="middle" rowspan="1" colspan="1">3000&#x02013;11,500</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Eosinophils (cells/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">198</td><td align="center" valign="middle" rowspan="1" colspan="1">322</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">840</td><td align="center" valign="middle" rowspan="1" colspan="1">712</td><td align="center" valign="middle" rowspan="1" colspan="1">234</td><td align="center" valign="middle" rowspan="1" colspan="1">100&#x02013;1250</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Lymphocytes (cells/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">1881</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>16,100</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">1400</td><td align="center" valign="middle" rowspan="1" colspan="1">1424</td><td align="center" valign="middle" rowspan="1" colspan="1">1989</td><td align="center" valign="middle" rowspan="1" colspan="1">1000&#x02013;4800</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Reactive lymphocytes (cells/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Monocytes (cells/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">396</td><td align="center" valign="middle" rowspan="1" colspan="1">483</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">420</td><td align="center" valign="middle" rowspan="1" colspan="1">445</td><td align="center" valign="middle" rowspan="1" colspan="1">585</td><td align="center" valign="middle" rowspan="1" colspan="1">149&#x02013;1350</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Basophils (cells/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rare</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Serum biochemistry</bold>
</td><td colspan="7" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Urea (mg/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">28</td><td align="center" valign="middle" rowspan="1" colspan="1">29</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">31</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">20&#x02013;56</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Creatinine (mg/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.8</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">1.2</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">0.5&#x02013;1.5</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">A.L.T. (U/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">40</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>19</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">51</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">21&#x02013;102</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Total protein (g/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.2</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>5.2</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">4.6</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">5.4&#x02013;7.1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Albumin (g/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.4</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>2.0</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>2.0</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">2.3&#x02013;3.1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Globulin (g/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.8</td><td align="center" valign="middle" rowspan="1" colspan="1">3.2</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>2.6</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">2.7&#x02013;4.4</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">A/G ratio</td><td align="center" valign="middle" rowspan="1" colspan="1">0.6</td><td align="center" valign="middle" rowspan="1" colspan="1">0.6</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">0.8</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">0.6&#x02013;1.1</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lipase (U/L)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">181</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25&#x02013;750</td></tr></tbody></table><table-wrap-foot><fn><p>Highlighted values were those considered to be different from the reference values for the species.</p></fn></table-wrap-foot></table-wrap></floats-group></article>